AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1

Historical Holders from Q1 2014 to Q1 2019

Type / Class
Debt / NOTE 2.500% 2/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2019 Q1 $0 $0 -$20,840,000 0
2018 Q4 $21,164,000 $20,840,000 +$27,695 100.0% 9
2018 Q3 $21,168,000 $21,157,000 -$19,787 100.0% 9
2018 Q2 $21,188,000 $21,933,000 -$8,463,193 100.0% 9
2018 Q1 $21,608,000 $30,019,811 +$8,447,911 100.0% 11
2017 Q4 $21,202,000 $21,208,542 -$276,829 100.0% 10
2017 Q3 $21,237,000 $22,502,961 -$17,754,380 104.17% 11
2017 Q2 $38,174,000 $39,681,566 -$170,888,151 104.0% 13
2017 Q1 $194,558,000 $212,339,691 -$20,352,219 109.25% 29
2016 Q4 $202,207,000 $286,123,558 +$6,924,912 141.41% 28
2016 Q3 $201,310,000 $227,670,676 +$3,488,981 112.81% 30
2016 Q2 $189,113,000 $209,111,391 +$2,799,996 110.53% 31
2016 Q1 $199,145,000 $216,207,454 -$396,601,348 108.49% 27
2015 Q4 $185,454,000 $638,804,000 -$22,023,570 126.1% 31
2015 Q3 $197,332,000 $320,216,000 -$11,572,212 161.16% 25
2015 Q2 $190,382,000 $492,291,000 +$15,456,373 258.6% 26
2015 Q1 $191,875,000 $398,604,520 +$11,132,904 207.7% 28
2014 Q4 $197,124,000 $329,441,000 -$121,050,589 167.14% 21
2014 Q3 $193,600,000 $392,859,992 +$136,209,655 134.0% 21
2014 Q2 $192,477,000 $204,310,000 +$11,569,465 106.15% 20
2014 Q1 $182,198,611 $185,244,707 +$163,708,707 101.73% 24